|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6420 USD | -2.87% |
|
+0.30% | -31.06% |
| 16/01 | Jaguar Health Inc - Co & unit entered license agreement with Woodward Specialty LLC - SEC filing | RE |
| 06/01 | Jaguar Health, Inc. announced that it has received $0.35 million in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 29.99L | - | - | - | ||
| 94TCr | |||||
| 57TCr | |||||
| 39TCr | |||||
| 37TCr | |||||
| 29TCr |
- Stock Market
- Equities
- JAGX Stock
- Charts Jaguar Health, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition